The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2021
DOI: 10.1007/s00234-021-02838-0
|View full text |Cite
|
Sign up to set email alerts
|

Influence of renal impairment on neurologic outcomes following mechanical thrombectomy in acute vertebrobasilar stroke

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(11 citation statements)
references
References 35 publications
1
10
0
Order By: Relevance
“…14,[16][17][18][21][22][23][24] The association of RI with an increased risk of 3-month mortality held also for adjusted data (six studies; OR, 1.84; 95% CI, 1.45-2.33; I 2 = 74%). 14,16,17,[22][23][24] The details are shown in Figure 3.…”
Section: Study Quality and Publication Biasmentioning
confidence: 79%
See 2 more Smart Citations
“…14,[16][17][18][21][22][23][24] The association of RI with an increased risk of 3-month mortality held also for adjusted data (six studies; OR, 1.84; 95% CI, 1.45-2.33; I 2 = 74%). 14,16,17,[22][23][24] The details are shown in Figure 3.…”
Section: Study Quality and Publication Biasmentioning
confidence: 79%
“…The risk of 3-month poor functional outcome in patients with RI was 2.13 times higher than that in patients without RI; the pooled OR was 2.13 (95% CI, 1.77–2.56; I 2 = 45%). Five studies 14 , 16 , 17 , 22 , 24 reported adjusted data on the association between RI and 3-month poor functional outcomes after EVT. The risk of 3-month poor functional outcome in patients with RI was higher than that in patients without RI; the pooled OR was 1.49 (95% CI, 1.17–1.90; I 2 = 58%).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The majority of the trials assessing BT investigate ACS subjects only or do not analyse the PCS subgroup separately [ 36 , 37 ]. A meta-analysis comparing BT to standard medical treatment specifically in PCS did reveal a significant increase in sICH, but not in 90-day mortality [ 38 ]. Unfortunately, standard medical treatment was defined as any antithrombotic treatment including antiplatelets, IVT or both, making results not exactly applicable to this discussion.…”
Section: Discussionmentioning
confidence: 99%
“…Other findings associated with the risk of poor outcomes were RF and PAD. RF is a well-known risk factor for a worse stroke prognosis after EVT and for any ICH in PCS [ 37 , 38 , 39 ]. As for PAD, we suggest that this factor was linked to an increased risk of poor outcomes because it is a marker of an unfavourable cardiovascular profile and is linked to increased mortality rates in general [ 40 ].…”
Section: Discussionmentioning
confidence: 99%